Literature DB >> 375096

Systemic candidiasis in mice treated with prednisolone and amphotericin B. 2. Ultrastructure and evidence for fungal toxin.

W Blyth, G E Stewart.   

Abstract

The principal ultrastructural changes in cells of Candida albicans treated with amphotericin B (AmB), either in vitro or in vivo, and in the presence or absence of prednisolone included plasmolysis, vacuolation and destruction of organelles. Lamination of the cell wall, although discernible after 4 h antibiotic treatment in vitro, was conspicuous in vivo, especially in prednisolone-treated mice given AmB 72 h after inoculation and was seen in both phagocytosed cells and those free in inflammatory exudates. Somatic extracts from control cells and somatic extracts and leachates from AmB-treated cells showed the presence of low-grade toxic components when given i.p. to mice receiving antinomycin D(AMD) s.c. Culture filtrates were negative. Eighteen hour cultures were more toxic than those grown for 3 days and no toxicity was shown for cultures after 8 or 14 days. The behaviour of toxic materials during electrophoresis in polyacrylamide gels suggested that they were proteins of relatively high molecular weight.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 375096     DOI: 10.1007/bf00429593

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  SOME OBSERVATIONS ON THE CYTOLOGY OF CANDIDA ALBICANS.

Authors:  A BAKERSPIGEL
Journal:  J Bacteriol       Date:  1964-01       Impact factor: 3.490

2.  Pathogenicity of Candida.

Authors:  S MOURAD; L FRIEDMAN
Journal:  J Bacteriol       Date:  1961-04       Impact factor: 3.490

3.  Candida protoplasts and their ultrastructure.

Authors:  B M Partridge; J A Drewe
Journal:  Sabouraudia       Date:  1974-07

4.  Candida albicans and the chemotaxis of polymorphonuclear neutrophils.

Authors:  T J Denning; R R Davies
Journal:  Sabouraudia       Date:  1973-11

5.  An examination of the production of hydrolytic enzymes and toxins by pathogenic strains of Candida albicans.

Authors:  F W Chattaway; F C Odds; A J Barlow
Journal:  J Gen Microbiol       Date:  1971-08

6.  ["Canditoxin", a new toxic substance isolated from Candida albicans. 2. Isolation and purification of the substance and its toxicity].

Authors:  K Iwata; K Uchida
Journal:  Igaku To Seibutsugaku       Date:  1967-06-10

7.  Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth.

Authors:  E F Gale; A M Johnson; D Kerridge; T Y Koh
Journal:  J Gen Microbiol       Date:  1975-03

8.  Ultrastructure of blastospores of Candida albicans after permanganate fixation.

Authors:  L F Montes; T A Patrick; S A Martin; M Smith
Journal:  J Invest Dermatol       Date:  1965-09       Impact factor: 8.551

9.  Systemic candidiasis in mice treated with prednisolone and amphotericin B. 1. Morbidity, mortality and inflammatory reaction.

Authors:  W Blyth; G E Stewart
Journal:  Mycopathologia       Date:  1978-12-29       Impact factor: 2.574

10.  CYTOLOGY OF CANDIDA ALBICANS AS INFLUENCED BY DRUGS ACTING ON THE CYTOPLASMIC MEMBRANE.

Authors:  G R GALE
Journal:  J Bacteriol       Date:  1963-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.